Pharmaceutical intermediates

Levocetirizine dihydrochloride Intermediates

1 pharmaceutical intermediate for Levocetirizine dihydrochloride. Indication: Respiratory hypersensitivity; Allergic dermatitis; Urticaria; Pruritus; Allergic rhinitis.

Submit a Project All intermediates

About Levocetirizine dihydrochloride

Originator: Ucb Inc.
Indication: Respiratory hypersensitivity; Allergic dermatitis; Urticaria; Pruritus; Allergic rhinitis
Approved Date: 05/25/2007

Available intermediates

1 intermediate currently listed for Levocetirizine dihydrochloride. Request specifications, documentation or a quotation for any item below.

Levocetirizine dihydrochloride intermediates
Product Name	CAS No.	Molecular Formula	Physical Properties
2-chloroethoxyacetonitrile	31250-08-5	/	/

Other programs under L

(LCZ696)Lanifibranor Lapatinib Larotrectinib Lasmiditan Lazertinib Mesylate Lemborexant Lenacapavir sodium

Building toward Levocetirizine dihydrochloride?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

Submit a Project Talk to the team

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here